A startup banks $66M to pursue ‘inclusive precision medicine’

With backers such as Regeneron’s venture arm, Actio Biosciences is working on medicines that counter a wide range of disease-causing genetic mutations in conditions like epilepsy and Charcot-Marie-Tooth disease.

Jun 18, 2025 - 13:40
 0
A startup banks $66M to pursue ‘inclusive precision medicine’

With backers such as Regeneron’s venture arm, Actio Biosciences is working on medicines that counter a wide range of disease-causing genetic mutations in conditions like epilepsy and Charcot-Marie-Tooth disease.